Biocytogen Enters into Antibody Evaluation, Option and License Agreement with Myricx for ADC Development Read more
Broad Institute of MIT and Harvard announces a new research alliance with Novo Nordisk to identify therapeutic targets for type 2 diabetes and cardiometabolic diseases Read more
TC BioPharm Announces Grant Funding in Collaboration with Queen Mary University of London (QMUL) Read more
Veracyte and Gustave Roussy Announce Collaboration to Help Biopharmaceutical Companies Accelerate Development of Novel Cancer Therapies Read more
Mirum Pharmaceuticals Completes Acquisition of Bile Acid Product Portfolio for Treatment of Rare Liver Diseases from Travere Therapeutics Read more
Zenas BioPharma Announces Strategic License and Collaboration Agreement with Bristol Myers Squibb to Develop and Commercialize Novel Bi-Functional Antibody Obexelimab in Japan, South Korea, Taiwan, Singapore, Hong Kong and Australia Read more
GSK’s regulatory submission accepted for review by Japanese regulator for use of Nucala (mepolizumab) in adults with chronic rhinosinusitis with nasal polyps Read more